NEWTON BIOCAPITAL
Newton Biocapital is a Venture Capital Fund incorporated in Belgium, focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for the prevention and treatment of chronic diseases. Their approach as lead investor is to support promising start-up projects as well as neglected or undervalued late-stage projects, in order to mitigate the risks and to create investor value. The leadership team consi.sts of specialists with long-standing management and investor experience who coach bio-entrepreneurs through the development stages of their projects.
NEWTON BIOCAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
2017-01-01
Status:
Active
Technology used in webpage:
Japanese Yen Combell
Similar Organizations
Felix Capital
Felix Capital is a venture fund that focuses on digital commerce, digital media, and information technology companies.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-24 | NeuVasQ | Newton Biocapital investment in Series A - NeuVasQ | 20 M EUR |
| 2021-05-26 | EditForce | Newton Biocapital investment in Venture Round - EditForce | 800 M JPY |
| 2021-02-24 | DeuterOncology | Newton Biocapital investment in Seed Round - DeuterOncology | N/A |
| 2020-11-30 | Perseus Proteomics | Newton Biocapital investment in Venture Round - Perseus Proteomics | 140 M JPY |
| 2020-11-04 | AbolerIS Pharma | Newton Biocapital investment in Seed Round - AbolerIS Pharma | 2.5 M EUR |
| 2020-07-30 | J-Pharma | Newton Biocapital investment in Series D - J-Pharma | 1.75 M JPY |
| 2019-11-06 | Acticor Biotech | Newton Biocapital investment in Series B - Acticor Biotech | 7 M EUR |
| 2019-03-01 | EditForce | Newton Biocapital investment in Series B - EditForce | 870 M JPY |
| 2018-10-17 | Acticor Biotech | Newton Biocapital investment in Series B - Acticor Biotech | 15.3 M EUR |
| 2018-10-16 | Sequana Medical | Newton Biocapital investment in Series D - Sequana Medical | 8.5 M EUR |